INHALED DRUG
DELIVERY
(IDD)

Conference Date: 09-10 Nov 2010
Conference Ref: N11-8010
Fee: £1320 + VAT
Venue: Le Meridien Piccadilly, London

Discounted fee of £1700 + VAT if booked with N11-8010 - DEVEOPING DRY POWDER INHALERS Pre-Conference Workshop on 08 Nov 2010

INTRODUCTION

The conference will focus on some of the therapeutic advances that have been made recently. Also providing an update on how genetics is beginning to unravel our understanding of asthma and what the impact of this may be on inhaled drug therapies, clearly a significant factor when considering the future of your inhaled drug business. Furthermore, will this cause the switch to inhaled systemic drug therapies to gain momentum? However, asthma and COPD inhaled drug delivery will be here for a long time yet, so we examine the issues of bioequivalence and product and device differentiation and how this may affect your market position. Updates on a number of devices that are new and will be entering the market shortly or are looking for a market entry will be showcased. New entrants have to bring something unique and cost effective to become a key player and this event will discuss pathways to success.

This is your opportunity to ensure you hear directly from key technical and market leaders about how the current level of knowledge will affect the future and potentially your business plans. This conference is dedicated to helping you with real, current issues and providing the latest state of knowledge across a number of critical development aspects of inhaled drug delivery – one not to be missed.

WHO SHOULD ATTEND

This major international conference will be of importance to: Directors, Senior Executives in R & D, Heads of Medical Departments, Pharma Product Development Scientists, Business Development Managers, Product Development Managers and Project Co-Ordinators in Manufacturing, R&D and Marketing in the field of Inhaled Drug Delivery.

Programme at a Glance:

• New Developments in Genetics and COPD
• Identifying Therapeutic Targets for Lung Disease
• The Challenge of Regulating Inhaler Equivalence
• Current Market Trends in Inhaled Medicine
• Staccato Technology – Beyond the First Product Filling
• Nanoparticles – the Application and Possibilities in Inhaled Delivery
• Designing Drug Delivery Devices
• Plasma: Meeting the HFA Challenge – The Latest Technology is Here
• SensoHaler – What it Can Do for You and Patients
• Prohaler Technology Update
• The UK Strategy for COPD – Developing a Health Strategy
• New Therapies for Lung Disease
• Electronic Nose Sniffs Out Asthma

‘Increase your networking opportunities by attending the drinks reception and conference dinner which forms part of the conference package’

After Dinner Speaker : Dr Brian Whittle, GW Pharma

Co-Chairmen
Day One: Dr Steve Nichols OINDP Specialist Consultant, UK
Day Two: Dr Ian Smith Director H12 Consulting, formerly Executive Director, Pfizer Ltd, UK
With a Panel of Expert Speakers

2010 Inhaled Drug Delivery RESEARCH POSTER COMPETITION - Click here to find out more

EXHIBITION OPPORTUNITIES AVAILABLE – contact Vicki Elliott on vicki@management-forum.co.uk

To book your place, please click here.